Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial

Watchlist | Portfolio | Dashboard

Contact

quotes
- Price Overview
- Performance Report
charts
- Interactive Chart
- Snapshot Chart
technicals
company
analysts
- Earnings Estimates
- Analyst Ratings
financials

Artelo Biosciences Inc (ARTL)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

News & Headlines for [[ item.sessionDateDisplayLong ]]

Notes

Alerts

Watch

Help

Artelo Biosciences Presents Preliminary Data on ART27.13 for Cancer-Related Anorexia at International Conference Quiver Quantitative, Inc. - Mon Dec 9, 6:26PM CST

Artelo Biosciences presented positive preliminary data on ART27.13 for cancer-related anorexia at an international conference.Quiver AI SummaryArtelo Biosciences, Inc. has announced preliminary results...

Artelo Biosciences Announces Presentation of Phase 1 Data with ART27.13 in Cancer-Related Anorexia GlobeNewswire - Mon Dec 9, 8:15AM CST

Artelo Biosciences to Present Innovations in Cannabinoid-Derived Drug Development at Boston Summit Quiver Quantitative, Inc. - Mon Nov 18, 5:52PM CST

Artelo Biosciences will present innovative drug development data at the Cannabinoid-Derived Drug Development Summit in Boston.Quiver AI SummaryArtelo Biosciences, Inc. announced that Professor Saoirse...

Artelo Biosciences to Present Key Data on Three Development Programs at the 7th Cannabinoid Drug Development Summit GlobeNewswire - Mon Nov 18, 7:30AM CST

Artelo Biosciences Announces Promising New Data on Novel Non-Opioid Treatment Approach for Osteoarthritis Pain at the 13th Annual Musculoskeletal Repair and Regeneration Symposium GlobeNewswire - Wed Nov 13, 7:30AM CST

Artelo Biosciences Reports Third Quarter 2024 Financial Results and Provides Business Update GlobeNewswire - Tue Nov 12, 7:00AM CST

Artelo Biosciences Announces Acceptance of ART26.12 into the National Institutes of Health’s “Preclinical Screening Platform for Pain” Program GlobeNewswire - Tue Nov 5, 7:30AM CST

Artelo Biosciences CEO to Participate in Fireside Chat at the Maxim Group Virtual Healthcare Summit on October 16th GlobeNewswire - Wed Oct 9, 8:00AM CDT

Artelo Biosciences Completes Enrollment of the First Three Cohorts in its CAReS Study Evaluating ART27.13 for the Treatment of Cancer-Related Anorexia and Weight Loss Globe Newswire - Tue Jul 19, 2022

Initiates Fourth Cohort at a 650-Microgram Dose with Data Expected in Q4 2022 ...